Outpatient Facility Registration Submission

The Authorizing Official Signature section is appended to the bottom of the summary page to allow you to attest to the registration.

screen shot of "Authorizing Official Signature" area of the registration summary page for self-attestation

Registration Submission AO Attestation Controls
Control Description

Textbox

"Please provide any additional information that may be helpful in reviewing this registration for 340B eligibility:"

Type any comments that will help OPA in approving the registration.

Checkbox

"By checking this box, I confirm that I have read the above statements and fully understand my obligations."

Select this box to submit the registration or reinstatement for OPA approval.

Cancel

Exit from the attestation page without taking action.

Submit

After selecting the check box to authorize the submission, click this button to submit the registration or reinstatement for OPA approval. The submission confirmation page will be displayed.

OPA will review the registration and may request more information to verify eligibility. Otherwise, OPA will review the registration and notify you when the registration is approved.

Upon clicking the Submit button, the ClosedPC External user who is designated as a Primary Contact for an entity. This user can enter registrations and update entity information. This user can enter registrations, and update entity information. Any changes to an entity performed by the PC user must be attested to by the AO for that entity. or AO will see the Outpatient Registration Submission confirmation page.

The user must click the OK button to return to your My Dashboard where the new registration will appear under My Pending.

Outpatient Facility Registration Summary page

Once the registration is approved by OPA, both the AO and PC will both receive a 340B Participation Approval email. The entity's 340B status will be updated to "Approved" and the entity's enrollment in the 340B program will start on the first day of the next quarter.